June 23, 2022 PALO ALTO, Calif. — In analyzing two-year data from SightGlass Vision’s CYPRESS clinical trial, experts have learned that the...
June 1, 2022 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE There is good reason to slow the progression of juvenile-onset myopia....
June 1, 2022 By Dean Psarakis, B.Optom, Senior Research Optometrist, Brien Holden Vision Institute Novel spectacle designs comprising D.I.M.S., H.A.L.T., and D.O.T....
sponsored content June 1, 2022 One of few spectacle lenses available to slow the progression of myopia, SightGlass Vision’s novel Diffusion Optics...
April 4, 2022 To find out what’s new with CooperVision Specialty EyeCare, particularly its growing list of orthokeratology materials and designs, Review...
March 24, 2022 PALO ALTO, Calif. — SightGlass Vision announced the appointment of three new leadership positions to its executive team. Andrew...
December 15, 2021 By Joe Rappon, OD, MS, FAAO, and Kylvin Ho, OD, FIAOMC As children continue to develop myopia at earlier...
sponsored content November 1, 2021 By Mark Bullimore, MCOptom, PhD, FAAO Effective spectacle options for myopia control have finally arrived. They are...
June 8, 2021 SAN RAMON, Calif. — CooperVision is slated to present research findings from more than 20 investigations at the upcoming...
April 12, 2021 CLICK HERE to view the presentation after April 29, 2021. The Ophthalmology Innovation Summit (OIS) will host a virtual...
March 3, 2021 Rick Gadd, President, Essilor North America, recently met with Review of Myopia Management’s Editor-in-Chief John Sailer to discuss the company’s...
March 3, 2021 Last month, CooperCompanies and EssilorLuxottica announced that they were teaming up to acquire SightGlass Vision. The goal of the joint...
February 3, 2021 SAN RAMON, Calif. and CHARENTON-LE-PONT, France – CooperCompanies and EssilorLuxottica entered a joint venture agreement to accelerate commercialization of...
June 3, 2020 PALO ALTO, California – SightGlass Vision, Inc. today announced it has achieved Conformité Européene (CE) Mark declaration on its first product...
April 2, 2020 Palo Alto, California – SightGlass Vision, Inc., a clinical-stage life sciences company focused on ending myopia, announced topline results from a...
Tens of millions of myopic children around the world need our help.
CYPRESS is a multi-center, double-masked, randomized controlled pivotal clinical study.
Jobson Medical Information will be the official North American media sponsor.
Jobson Optical Research, sponsored by Essilor, polled more than 300 optometrists in the U.S.